These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11297566)

  • 41. Progress in the search for neuronal mechanisms coupling type 2 diabetes to obesity.
    Schwartz MW
    J Clin Invest; 2001 Oct; 108(7):963-4. PubMed ID: 11581296
    [No Abstract]   [Full Text] [Related]  

  • 42. Proopiomelanocortin (POMC): the cutaneous roles of its melanocortin products and receptors.
    Millington GW
    Clin Exp Dermatol; 2006 May; 31(3):407-12. PubMed ID: 16681590
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Screening of mutations in genes of pro-opiomelanocortin in patients with constitutional exogenous obesity].
    Pankov IuA; Iatsyshina SB; Karpova SK; Chekhranova MK; Popova IuP; Grigorian ON; Rogaev EI
    Vopr Med Khim; 2002; 48(1):121-30. PubMed ID: 12068494
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Pro162 variant is a loss-of-function mutation of the human melanocortin 1 receptor gene.
    Jiménez-Cervantes C; Olivares C; González P; Morandini R; Ghanem G; García-Borrón JC
    J Invest Dermatol; 2001 Jul; 117(1):156-8. PubMed ID: 11442765
    [No Abstract]   [Full Text] [Related]  

  • 45. A novel melanocortin 3 receptor gene (MC3R) mutation associated with severe obesity.
    Lee YS; Poh LK; Loke KY
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1423-6. PubMed ID: 11889220
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The genetics of malignant melanoma: lessons from mouse and man.
    Chin L
    Nat Rev Cancer; 2003 Aug; 3(8):559-70. PubMed ID: 12894244
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans.
    Hinney A; Schmidt A; Nottebom K; Heibült O; Becker I; Ziegler A; Gerber G; Sina M; Görg T; Mayer H; Siegfried W; Fichter M; Remschmidt H; Hebebrand J
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1483-6. PubMed ID: 10199800
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Binge eating as a phenotype of melanocortin 4 receptor gene mutations.
    Farooqi IS; Yeo GS; O'Rahilly S
    N Engl J Med; 2003 Aug; 349(6):606-9; author reply 606-9. PubMed ID: 12908459
    [No Abstract]   [Full Text] [Related]  

  • 49. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity.
    Vaisse C; Clement K; Durand E; Hercberg S; Guy-Grand B; Froguel P
    J Clin Invest; 2000 Jul; 106(2):253-62. PubMed ID: 10903341
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The intercausality of neuroendocrine and immune disorders in the pathogenesis of gestosis in pregnant women with hypertension].
    Malakhova EI; Lopukhin VO; Dolgov AM
    Akush Ginekol (Mosk); 1993; (3):3-5. PubMed ID: 8048683
    [No Abstract]   [Full Text] [Related]  

  • 51. Psychoneuroendocrine stress-induced syndromes.
    Coculescu M
    Physiologie; 1989; 26(3):233-50. PubMed ID: 2510203
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phenotypic expression of melanocortin-1 receptor mutations in Black Jamaicans.
    McKenzie CA; Harding RM; Tomlinson JB; Ray AJ; Wakamatsu K; Rees JL
    J Invest Dermatol; 2003 Jul; 121(1):207-8. PubMed ID: 12839583
    [No Abstract]   [Full Text] [Related]  

  • 53. Skin type, melanoma, and melanocortin 1 receptor variants.
    Healy E; Todd C; Jackson IJ; Birch-Machin M; Rees JL
    J Invest Dermatol; 1999 Apr; 112(4):512-3. PubMed ID: 10201538
    [No Abstract]   [Full Text] [Related]  

  • 54. The brainstem is a key target for neuroendocrine research on obesity.
    Takahashi K
    Endocrinology; 2003 Nov; 144(11):4690-1. PubMed ID: 14578220
    [No Abstract]   [Full Text] [Related]  

  • 55. Molecular cloning of a novel human melanocortin receptor.
    Chhajlani V; Muceniece R; Wikberg JE
    Biochem Biophys Res Commun; 1996 Jan; 218(2):638. PubMed ID: 8561809
    [No Abstract]   [Full Text] [Related]  

  • 56. XVIII Annual Meeting of the Sociedad Latinoamericana De Endocrinologia Pediatrica (SLEP).
    Martinez A
    Pediatr Endocrinol Rev; 2007 Jun; 4(4):366-7. PubMed ID: 17643086
    [No Abstract]   [Full Text] [Related]  

  • 57. Psychopathological aspects of neuroendocrine diseases: possible parallels with the psychoendocrine aspects of normal aging.
    Brambilla F
    Psychoneuroendocrinology; 1992 Aug; 17(4):283-91. PubMed ID: 1359603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rapid genotyping of melanocortin-1 receptor with use of fluorescence-labeled oligonucleotides.
    Diefenbach K; Mrozikiewicz PM; Brien B; Landt O; Roots I
    Clin Chem; 2003 Mar; 49(3):507-9. PubMed ID: 12600969
    [No Abstract]   [Full Text] [Related]  

  • 59. Neuroendocrine function in obesity.
    Kopelman PG
    Clin Endocrinol (Oxf); 1988 Jun; 28(6):675-89. PubMed ID: 3075931
    [No Abstract]   [Full Text] [Related]  

  • 60. Once and again-issues surrounding replication in genetic association studies.
    Hirschhorn JN; Altshuler D
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4438-41. PubMed ID: 12364414
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.